Tooth Retention After Root Canal Treatment With Endomethasone N
NCT: NCT04945993 · ACTIVE_NOT_RECRUITING
Brief Summary
The aim of root canal treatment, or endodontic treatment, is to treat pulpal or periapical diseases and thus transform a pathological tooth into a healthy, asymptomatic and functional entity on the dental arch. The diagnosis of pulp pathology is based on the symptomatology described by the patient, on data from the clinical examination and tests performed as well as the radiographic examinations. Different families of root canal sealers are used in endodontics: cements based on zinc oxide-eugenol (ZOE), resin-based materials, and calcium silicate-based cements. They provide a stable and hermetic sealing. The Septodont laboratory has developed and manufactured endomethasone N, a zinc oxide-eugenol root canal sealer. The aim of this retro-prospective PMCF study is to collect long term clinical and safety data on root canal obturation after treatment or retreatment by Endomethasone N.
Frequently Asked Questions
What is Tooth Retention After Root Canal Treatment With Endomethasone N?
Tooth Retention After Root Canal Treatment With Endomethasone N is a clinical trial registered under NCT04945993. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04945993?
The current status of NCT04945993 (Tooth Retention After Root Canal Treatment With Endomethasone N) is: ACTIVE_NOT_RECRUITING.
When did Tooth Retention After Root Canal Treatment With Endomethasone N start?
Tooth Retention After Root Canal Treatment With Endomethasone N started on 2021-07-02.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.